Nutritionist and obesity: brief overview on efficacy, safety, and drug interactions of the main weight-loss dietary supplements

Luigi Barrea, Barbara Altieri, Barbara Polese, Barbara De Conno, Giovanna Muscogiuri, Annamaria Colao, Silvia Savastano, on Behalf of Obesity Programs of Nutrition, Education, Research and Assessment (OPERA) Group
{"title":"Nutritionist and obesity: brief overview on efficacy, safety, and drug interactions of the main weight-loss dietary supplements","authors":"Luigi Barrea, Barbara Altieri, Barbara Polese, Barbara De Conno, Giovanna Muscogiuri, Annamaria Colao, Silvia Savastano, on Behalf of Obesity Programs of Nutrition, Education, Research and Assessment (OPERA) Group","doi":"10.1038/s41367-019-0007-3","DOIUrl":null,"url":null,"abstract":"Over the past 20 years the use of dietary supplements as adjuvant therapy for weight loss gained growing favor among consumers and dietician–nutritionists, with the subsequent astounding increase in health costs. Despite the reassuring label of natural remedy for losing weight, dietary supplements contain a wide variety of ingredients on which available information is rather scanty and scientifically incomplete. Currently, there is little evidence that weight-loss supplements offer effective aids to reduce weight and meet criteria for recommended use. Robust, randomized, placebo-controlled studies to provide clear-cut scientific evidence of their efficacy and potential side effects in clinical practice are still lacking. Understanding the evidence for the efficacy, safety, and quality of these supplements among nutritionists and physicians is critical to counsel patients appropriately, especially considering the risk of serious adverse effects and interference with concomitant therapies. Detailed information on the efficacy and safety of the most commonly used weight-loss dietary supplements has been recently published by the National Institutes of Health (NIH). However, in this report the thorny issue that may result from drug interactions with weight-loss dietary supplements has been not sufficiently addressed. The aim of this review was to provide a synthetic, evidence-based report on efficacy and safety of the most commonly used ingredients in dietary supplements marketed for weight loss, particularly focusing on their possible drug interactions.","PeriodicalId":14202,"journal":{"name":"International journal of obesity supplements","volume":"9 1","pages":"32-49"},"PeriodicalIF":0.0000,"publicationDate":"2019-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1038/s41367-019-0007-3","citationCount":"25","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of obesity supplements","FirstCategoryId":"1085","ListUrlMain":"https://www.nature.com/articles/s41367-019-0007-3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 25

Abstract

Over the past 20 years the use of dietary supplements as adjuvant therapy for weight loss gained growing favor among consumers and dietician–nutritionists, with the subsequent astounding increase in health costs. Despite the reassuring label of natural remedy for losing weight, dietary supplements contain a wide variety of ingredients on which available information is rather scanty and scientifically incomplete. Currently, there is little evidence that weight-loss supplements offer effective aids to reduce weight and meet criteria for recommended use. Robust, randomized, placebo-controlled studies to provide clear-cut scientific evidence of their efficacy and potential side effects in clinical practice are still lacking. Understanding the evidence for the efficacy, safety, and quality of these supplements among nutritionists and physicians is critical to counsel patients appropriately, especially considering the risk of serious adverse effects and interference with concomitant therapies. Detailed information on the efficacy and safety of the most commonly used weight-loss dietary supplements has been recently published by the National Institutes of Health (NIH). However, in this report the thorny issue that may result from drug interactions with weight-loss dietary supplements has been not sufficiently addressed. The aim of this review was to provide a synthetic, evidence-based report on efficacy and safety of the most commonly used ingredients in dietary supplements marketed for weight loss, particularly focusing on their possible drug interactions.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
营养师与肥胖症:主要减肥膳食补充剂的功效、安全性和药物相互作用简介
在过去的 20 年里,使用膳食补充剂作为减肥辅助疗法越来越受到消费者和营养学家的青睐,随之而来的是医疗费用的惊人增长。尽管膳食补充剂被贴上了 "天然减肥良药 "的标签,但其所含成分种类繁多,现有资料十分匮乏,在科学上也不完整。目前,几乎没有证据表明减肥补充剂能有效减轻体重,并符合推荐使用的标准。在临床实践中,仍然缺乏可靠的、随机的、安慰剂对照研究来提供明确的科学证据,以证明其疗效和潜在的副作用。营养学家和医生了解这些营养补充剂的疗效、安全性和质量方面的证据,对于为患者提供适当的咨询至关重要,尤其是考虑到严重不良反应的风险和对同时进行的治疗的干扰。美国国立卫生研究院(NIH)最近公布了有关最常用的减肥膳食补充剂的功效和安全性的详细信息。然而,在这份报告中,减肥膳食补充剂与药物相互作用可能导致的棘手问题并未得到充分解决。本综述的目的是就市场上销售的减肥膳食补充剂中最常用成分的功效和安全性提供一份基于证据的合成报告,尤其关注它们可能产生的药物相互作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Cardiovascular effects of antiobesity drugs: are the new medicines all the same? Maternal obesity: focus on offspring cardiometabolic outcomes What is the best diet for cardiovascular wellness? A comparison of different nutritional models Sleep disturbances: one of the culprits of obesity-related cardiovascular risk? From obesity through gut microbiota to cardiovascular diseases: a dangerous journey
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1